Mixed results for oral treprostinil formulation at Phase III

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:605 / 605
页数:1
相关论文
共 50 条
  • [31] Phase III results reported for Prosorba
    不详
    DRUG NEWS & PERSPECTIVES, 1998, 11 (01) : 63 - 63
  • [32] Early phase III results for rituximab
    Senior, K
    LANCET ONCOLOGY, 2005, 6 (12): : 925 - 925
  • [33] Results from phase III trials
    不详
    BIOTECHNOLOGY LAW REPORT, 1999, 18 (03) : 262 - 265
  • [34] Inpatient Initiation of Oral Treprostinil in an Academic Medical System
    Hohlfelder, Benjamin
    Tonelli, Adriano R.
    Heresi, Gustavo A.
    Bair, Nancy
    Rahaghi, Franck F.
    Bauer, Seth R.
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (04) : 547 - 553
  • [35] Comparative evaluation of costs and healthcare resource utilization of oral selexipag versus inhaled treprostinil or oral treprostinil in patients with pulmonary arterial hypertension
    Papademetriou, Eros
    Liu, Xing
    Beaudet, Amelie
    Tsang, Yuen
    Potluri, Ravi
    Panjabi, Sumeet
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 644 - 655
  • [36] Safety And Feasibility Of Switching Between Oral And Parenteral Treprostinil
    Nathan, S. D.
    Hansdottir, S.
    Feldman, J.
    Ishizawar, D.
    Ivy, D.
    Schilz, R.
    Shapiro, S.
    White, R. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [37] Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial Hypertension
    Hopper, Rachel K.
    Ivy, D. Dunbar
    Yung, Delphine
    Mullen, Mary P.
    Hanna, Brian D.
    Kirkpatrick, Edward
    Hirsch, Russel
    Austin, Eric D.
    Fineman, Jeffrey
    Solum, Derek
    Deng, C. Q.
    Feinstein, Jeffrey A.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (01) : 94 - 100
  • [38] RESULTS OF THE PHASE-III TRIALS WITH IMAGENT GI AS AN ORAL MAGNETIC-RESONANCE CONTRAST AGENT
    MATTREY, RF
    TRAMBERT, MA
    BROWN, JJ
    BRUNETON, JN
    YOUNG, SW
    SCHOOLEY, GL
    INVESTIGATIVE RADIOLOGY, 1991, 26 : S65 - S66
  • [39] Long term results of a randomized phase III trials with preoperative chemotherapy in resectable oral cavity cancer
    Bossi, Paolo
    Lisa, Licitra
    Guzzo, Marco
    Lo Vullo, Salvatore
    Mariani, Luigi
    Locati, Laura D.
    Quattrone, Pasquale
    Valvo, Francesca
    Cantu, Giulio
    ANNALS OF ONCOLOGY, 2006, 17 : 179 - 179
  • [40] Talactoferrin in Severe Sepsis: Results From the Phase II/III Oral tAlactoferrin in Severe sepsIS Trial
    Vincent, Jean-Louis
    Marshall, John C.
    Dellinger, R. Phillip
    Simonson, Steven G.
    Guntupalli, Kalpalatha
    Levy, Mitchell M.
    Singer, Mervyn
    Malik, Rajesh
    CRITICAL CARE MEDICINE, 2015, 43 (09) : 1832 - 1838